Rosetta Inpharmatics Inc. 12040 115th Ave. NE Kirkland, WA 98034-6900 Phone: (425) 820-8900 Fax: (425) 821-5354 www.rii.com Management Stephen Friend, president and CEO. Mark Boguski, senior vice president, research and development John King, senior vice president, chief operating officer Gregory Sessler, senior vice president, chief financial officer Roland Stoughton, vice president, bioinformatics Overview Rosetta was founded in 1996 by its president and CEO, Stephen

Rigel Inc. 240 East Grand Avenue South San Francisco, CA 94080 Phone: (650) 624-1100 Fax: (650) 624-1101 www.rigel.com Management James Gower, president and CEO Brian Cunningham, senior vice president, chief operating officer and chief financial officer Donald Payan, executive vice president and chief scientific officer Jim Welch, vice president, finance and administration Overview Rigel Inc., of South San Francisco, was founded in 1996. The company s target discovery

Pharmagene plc Orchard Road Royston Hertfordshire, SG8 5HD United Kingdom Phone: +44 (0) 1763 211600 Fax: +44 (0) 1763 211630 www.pharmagene.com Management Nowell Stebbing, chairman Alastair Riddell, CEO Robert Coleman, chief scientific officer Neil Johnston, chief financial officer J. William Buckie, vice president, finance Stephen Rhind, vice president, corporate development Tony Brown, vice president, operations Overview Royston, UK-based Pharmagene was founded in

Paradigm Genetics Inc. 104 Alexander Drive, Building 2 P.O. Box 14528 Research Triangle Park, NC 27709 Phone: (919) 425-3000 Fax: (919) 544-8193 www.paragen.com Management John Ryals, president and CEO Henry Nowak, general counsel and vice president, intellectual property Ian Howes, chief financial officer and vice president, finance and operations Athanasios Maroglou, vice president, project management John Hamer, vice president, research Craig Liddell, vice president

Oxford GlycoSciences plc The Forum 86, Milton Park Abingdon, Oxon OX14 4RY UK Phone: +44 1235-208000 Fax: +44 1235-208020 www.ogs.com Management Kirk Raab, chairman Michael Kranda, CEO Raj Parekh, chief scientific officer Stephen Parker, finance director Carl Foster, senior vice president, business development Chris Moyses, clinical and development director John Ilett, legal director and secretary Overview Oxford GlycoSciences plc (OGS), of Oxford, UK, was founded in

Orchid BioSciences Inc. 303 College Road East Princeton, NJ 08540 Phone: (609) 750-2200 Toll Free: (888) 398-9352 Fax: (609) 750-2250 www.orchidbio.com Management Dale Pfost, chairman, president and CEO Donald Marvin, chief financial officer, chief operating officer and senior vice president, corporate development Michael Boyce-Jacino, chief technology officer and vice president, research and development Christopher Ashton, vice president and managing director, European operations

Onyx Pharmaceuticals Inc. 3031 Research Drive Richmond, CA 94806 Phone: (510) 222-9700 Fax: (510) 222-9758 www.onyx-pharm.com Management Hollings C. Renton, chairman and CEO Leonard E. Post, senior vice president, research and development. Helen S. Kim, vice president, corporate development Judith Blakemore, vice president, strategic programs Greg J. Giotta, vice president and chief legal counsel Mary Ann Rafferty, vice president, organization development Overview Onyx

Myriad Genetics Inc. 320 Wakara Way Salt Lake City, UT 84108 Phone: (801) 584-3600 Fax: (801) 584-3640 www.myriad.com Management John Horan, chairman Walter Gilbert, director and vice chairman Peter Meldrum, director, president and CEO Adrian Hobden, president, Myriad Pharmaceuticals Inc. Gregory Critchfield, president Myriad Genetics Laboratories Inc. Mark Skolnick, executive vice president and chief scientific officer John Holmen, vice president, informatics Arnold Oliphant

Millennium Pharmaceuticals Inc. 75 Sidney St. Cambridge, MA 02139 Phone: (617) 679-7000 Fax: (617) 374-9379 www.millennium.com Management Mark Levin, chairman and CEO Julian Adams, senior vice president, research & development Steve Holtzman, chief business officer Kevin Starr, chief financial officer Frank Lee, chief technology officer Michael Pavia, chief technology officer Robert Tepper, chief scientific officer Kenneth Conway, president, Millennium Predictive Medicine Alan

MediGene AG Lochhamer Str. 11 D-82152 Planegg/Martinsried Germany Phone: 49-89-89 56 32-0 Fax: 49-89-89 56 32-20 www.medigene.de Management Peter Heinrich, CEO Johanna Holldack, chief operating officer Erwin B hm, vice president, clinical development and regulatory affairs Angelika Heinz, vice president, finance Thomas Henkel, vice president, research Gerard Luyben, vice president, controlling Martin P hlchen, vice president, business & corporate development Overview

Maxygen Inc. 515 Galveston Drive Redwood City, CA 94063 Phone: (650) 298-5300 Fax: (650) 364-2715 www.maxygen.com Management Isaac Stein, chairman Russell Howard, CEO Simba Gill, president Mike Rabson, general counsel and senior vice president, legal affairs Overview Maxygen Inc., of Redwood City, Calif., was spun out in 1997 from a London-based Glaxo Wellcome plc unit, Affymax Research Institute, of Santa Clara, Calif. The company has a portfolio of proprietary

Lynx Therapeutics Inc. 25861 Industrial Blvd. Hayward, CA 94545 Phone: (510) 670-9300 Fax: (510) 670-9302 www.lynxgen.com Management Norrie Russell, president and CEO Edward Albini, chief financial officer and secretary Glenn Albrecht, vice president, molecular biology Benjamin Bowen, vice president, applications development Kevin Corcoran, vice president, operations Stephen Macevicz, vice president, intellectual property Jen-i Mao, vice president, genetic analysis Kathy San

LION Bioscience AG Im Neuenheimer Feld 515-517 Heidelberg, D-69120 Germany Phone: +49 6221-4038-0 Fax: +49 6221-4038-101 www.lionbioscience.com Management Friedrich von Bohlen, CEO Jan Mous, chief scientific officer Klaus Sprockamp, chief financial officer, chief operating officer Georg Casari, vice president, life science informatics research David Chilvers, vice president, sales and marketing Thure Etzold, managing director of LION Bioscience Ltd. Torsten Hoof, vice president

Lexicon Genetics Inc. 4000 Research Forest Drive The Woodlands, TX 77381-4287 Phone: (281) 364-0100, Toll Free: (800) 578-1972 Fax: (281) 364-0155 www.lexicongenetics.com Management Arthur Sands, president and CEO Julia P. Gregory, executive vice president and chief financial officer Jeffrey L. Wade, executive vice president and general counsel James R. Piggott, senior vice president of pharmaceutical biology Randall B. Riggs, senior vice president of business development Brian

Incyte Genomics Inc. 3160 Porter Drive Palo Alto, CA 94304 Phone: (650) 855-0555 Fax: (650) 855-0572 www.incyte.com Management Jeffrey Collinson, chairman Roy Whitfield, CEO Randal Scott, president and chief scientific officer David Briscoe, president, Incyte Europe Ltd. John Vuko, chief financial officer and executive vice president Mike Lack, chief operations officer Lee Bendekgey, general counsel Marian Marra, senior vice president, corporate development Jim Neal, executive

Hyseq Inc. 670 Almanor Avenue Sunnyvale, CA 94086 Phone: (408) 524-8100 Fax: (408) 524-8141 www.hyseq.com Management George Rathmann, chairman, president and CEO Mark Gitter, chief financial officer Radoje Drmanac, chief scientific officer James Fletcher, vice president, administration Overview Hyseq Inc. was founded in 1992. Its genomics platform has launched programs in sequencing, discovery of genes and of genetic variances linked to diseases, drug discovery and

Human Genome Sciences Inc. 9410 Key West Avenue Rockville, MD 20850 Phone: (301) 309-8504 Fax: (301) 309-8512 www.hgsi.com Management William Haseltine, chairman and CEO Craig Rosen, executive vice president, R&D David Stump, senior vice president, drug development Arthur Mandell, senior vice president, chief business officer Steven Mayer, senior vice president and chief financial officer James Davis, vice president, general counsel and secretary Susan Betesom McKay, senior vice

GPC Biotech AG Fraunhoferstra e 20 D-82152 Martinsried / Munich Germany Phone: +49 (0) 89 85 65 26 00 Fax: +49 (0) 89 85 65 2610 www.gpc-biotech.com Management Bernd R. Seizinger, president and CEO Mirko Scherer, vice president and chief financial officer Elmar Maier, vice president, business development, and chief operating officer, Munich Sebastian Meier-Ewert, vice president and head of research Overview In 2000, GPC Biotech was formed through the acquisition of the

Genzyme Molecular Oncology 5 Pleasant Street Connector PO Box 9322 Framingham, MA 01701 Phone: (508) 271-2627 Fax: (508) 271-2604 www.genzyme.com Management Gail Maderis, president Mark Enyedy, vice president, business development Mark Goldberg, vice president, medical affairs Clifford Hendrick, vice president, operations Katherine Klinger, senior vice president, research and development Overview Genzyme Molecular Oncology (GMO), of Cambridge, Mass., was formed in June